Toll Free: 1-888-928-9744
Published: Nov, 2014 | Pages:
31 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Mochida Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Mochida Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Mochida Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Mochida Pharmaceutical Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Mochida Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Mochida Pharmaceutical Co., Ltd.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Mochida Pharmaceutical Co., Ltd.'s pipeline products Reasons to buy - Evaluate Mochida Pharmaceutical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Mochida Pharmaceutical Co., Ltd. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Mochida Pharmaceutical Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Mochida Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Mochida Pharmaceutical Co., Ltd. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Mochida Pharmaceutical Co., Ltd. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Mochida Pharmaceutical Co., Ltd. Snapshot 5 Mochida Pharmaceutical Co., Ltd. Overview 5 Key Information 5 Key Facts 5 Mochida Pharmaceutical Co., Ltd. - Research and Development Overview 6 Key Therapeutic Areas 6 Mochida Pharmaceutical Co., Ltd. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Mochida Pharmaceutical Co., Ltd. - Pipeline Products Glance 12 Mochida Pharmaceutical Co., Ltd. - Late Stage Pipeline Products 12 Phase III Products/Combination Treatment Modalities 12 Mochida Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 Mochida Pharmaceutical Co., Ltd. - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 Mochida Pharmaceutical Co., Ltd. - Drug Profiles 16 dienogest 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 mesalamine ER 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 icosapent ethyl 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 etanercept biosimilar 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Drug to Inhibit Elovl-6 for Metabolic Diseases And Cardiovascular 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Mochida Pharmaceutical Co., Ltd. - Pipeline Analysis 22 Mochida Pharmaceutical Co., Ltd. - Pipeline Products by Target 22 Mochida Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration 23 Mochida Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type 24 Mochida Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action 25 Mochida Pharmaceutical Co., Ltd. - Recent Pipeline Updates 26 Mochida Pharmaceutical Co., Ltd. - Dormant Projects 27 Mochida Pharmaceutical Co., Ltd. - Discontinued Pipeline Products 28 Discontinued Pipeline Product Profiles 28 ulinastatin 28 Mochida Pharmaceutical Co., Ltd. - Locations And Subsidiaries 29 Head Office 29 Other Locations & Subsidiaries 29 Appendix 30 Methodology 30 Coverage 30 Secondary Research 30 Primary Research 30 Expert Panel Validation 30 Contact Us 31 Disclaimer 31
List of Tables Mochida Pharmaceutical Co., Ltd., Key Information 5 Mochida Pharmaceutical Co., Ltd., Key Facts 5 Mochida Pharmaceutical Co., Ltd. - Pipeline by Indication, 2014 7 Mochida Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014 8 Mochida Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014 9 Mochida Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2014 10 Mochida Pharmaceutical Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2014 11 Mochida Pharmaceutical Co., Ltd. - Phase III, 2014 12 Mochida Pharmaceutical Co., Ltd. - Phase II, 2014 13 Mochida Pharmaceutical Co., Ltd. - Phase I, 2014 14 Mochida Pharmaceutical Co., Ltd. - Preclinical, 2014 15 Mochida Pharmaceutical Co., Ltd. - Pipeline by Target, 2014 22 Mochida Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2014 23 Mochida Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2014 24 Mochida Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2014 25 Mochida Pharmaceutical Co., Ltd. - Recent Pipeline Updates, 2014 26 Mochida Pharmaceutical Co., Ltd. - Dormant Developmental Projects,2014 27 Mochida Pharmaceutical Co., Ltd. - Discontinued Pipeline Products, 2014 28 Mochida Pharmaceutical Co., Ltd., Subsidiaries 29
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.